vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $58.6M, roughly 1.3× Vitesse Energy, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 4.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -2.1%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.

PBYI vs VTS — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.3× larger
PBYI
$75.5M
$58.6M
VTS
Growing faster (revenue YoY)
PBYI
PBYI
+22.9% gap
PBYI
27.7%
4.8%
VTS
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-2.1%
VTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
VTS
VTS
Revenue
$75.5M
$58.6M
Net Profit
$-739.0K
Gross Margin
69.3%
Operating Margin
22.7%
-12.0%
Net Margin
-1.3%
Revenue YoY
27.7%
4.8%
Net Profit YoY
85.6%
EPS (diluted)
$0.26
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
VTS
VTS
Q4 25
$75.5M
$58.6M
Q3 25
$54.5M
$67.4M
Q2 25
$52.4M
$81.8M
Q1 25
$46.0M
$66.2M
Q4 24
$59.1M
$55.9M
Q3 24
$80.5M
$58.3M
Q2 24
$47.1M
$66.6M
Q1 24
$43.8M
$61.2M
Net Profit
PBYI
PBYI
VTS
VTS
Q4 25
$-739.0K
Q3 25
$8.8M
$-1.3M
Q2 25
$5.9M
$24.7M
Q1 25
$3.0M
$2.7M
Q4 24
$-5.1M
Q3 24
$20.3M
$17.4M
Q2 24
$-4.5M
$10.9M
Q1 24
$-4.8M
$-2.2M
Gross Margin
PBYI
PBYI
VTS
VTS
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
VTS
VTS
Q4 25
22.7%
-12.0%
Q3 25
17.6%
0.2%
Q2 25
12.7%
22.8%
Q1 25
8.7%
8.1%
Q4 24
22.6%
3.7%
Q3 24
27.4%
15.4%
Q2 24
-4.6%
25.2%
Q1 24
-5.3%
21.4%
Net Margin
PBYI
PBYI
VTS
VTS
Q4 25
-1.3%
Q3 25
16.2%
-1.9%
Q2 25
11.2%
30.2%
Q1 25
6.5%
4.0%
Q4 24
-9.2%
Q3 24
25.2%
29.9%
Q2 24
-9.6%
16.4%
Q1 24
-11.0%
-3.6%
EPS (diluted)
PBYI
PBYI
VTS
VTS
Q4 25
$0.26
$-0.01
Q3 25
$0.17
$-0.03
Q2 25
$0.12
$0.60
Q1 25
$0.06
$0.08
Q4 24
$0.40
$-0.15
Q3 24
$0.41
$0.53
Q2 24
$-0.09
$0.33
Q1 24
$-0.10
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
VTS
VTS
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$629.3M
Total Assets
$216.3M
$893.4M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
VTS
VTS
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
$4.5M
Q4 24
$101.0M
$3.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
PBYI
PBYI
VTS
VTS
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
VTS
VTS
Q4 25
$130.3M
$629.3M
Q3 25
$115.3M
$650.3M
Q2 25
$104.7M
$671.9M
Q1 25
$97.1M
$667.7M
Q4 24
$92.1M
$500.3M
Q3 24
$71.1M
$520.4M
Q2 24
$48.5M
$518.5M
Q1 24
$51.0M
$522.7M
Total Assets
PBYI
PBYI
VTS
VTS
Q4 25
$216.3M
$893.4M
Q3 25
$202.9M
$932.9M
Q2 25
$194.9M
$951.5M
Q1 25
$196.2M
$975.2M
Q4 24
$213.3M
$810.9M
Q3 24
$220.7M
$791.2M
Q2 24
$205.0M
$778.4M
Q1 24
$214.1M
$749.7M
Debt / Equity
PBYI
PBYI
VTS
VTS
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
VTS
VTS
Operating Cash FlowLast quarter
$14.4M
$37.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
VTS
VTS
Q4 25
$14.4M
$37.4M
Q3 25
$9.7M
$49.4M
Q2 25
$14.1M
$66.0M
Q1 25
$3.6M
$17.5M
Q4 24
$15.6M
$34.7M
Q3 24
$11.0M
$45.7M
Q2 24
$1.0M
$35.2M
Q1 24
$11.2M
$39.4M
Free Cash Flow
PBYI
PBYI
VTS
VTS
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
PBYI
PBYI
VTS
VTS
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
PBYI
PBYI
VTS
VTS
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
PBYI
PBYI
VTS
VTS
Q4 25
Q3 25
1.10×
Q2 25
2.41×
2.68×
Q1 25
1.21×
6.56×
Q4 24
Q3 24
0.54×
2.62×
Q2 24
3.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

VTS
VTS

Oil Reserves$54.5M93%
Natural Gas Reserves$4.2M7%

Related Comparisons